The role of oxidative stress in anticancer activity of sesquiterpene lactones

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 388, Issue 5, 2015, Pages 477-486

  Gach, Katarzyna ^a   Długosz, Angelika ^a   Janecka, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Alkylating agents; Apoptosis; GSH; Oxidative stress; ROS; Sesquiterpene lactones; Methylene lactones

Indexed keywords

ALANTOLACTONE; CARABRANOLIDE; COSTUNOLIDE; EUDESMANOLIDE DERIVATIVE; EUPALININ A; GERMACRANOLIDE DERIVATIVE; GLUTATHIONE; GUAIANOLIDE DERIVATIVE; HELENALIN; PARTHENOLIDE; PSEUDOGUAIANOLIDE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SALOGRAVIOLIDE A; SESQUITERPENE LACTONE; TELEKIN; TERPENOID; UNCLASSIFIED DRUG; XANTHANOLIDE DERIVATIVE; ANTINEOPLASTIC AGENT; LACTONE; SESQUITERPENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; DRUG STRUCTURE; HUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; APOPTOSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; HUMANS; LACTONES; MOLECULAR STRUCTURE; NEOPLASMS; OXIDATIVE STRESS; PLANTS, MEDICINAL; REACTIVE OXYGEN SPECIES; SESQUITERPENES;

EID: 84939417655     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-015-1096-3     Document Type: Article

References (77)

1. Beekman AC, Woerdenbag HJ, van Uden W, Pras N, Konings AW, Wikström HV, Schmidt TJ (1997) Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones. J Nat Prod 60:252-257
2. + T cells by multiple mechanisms. Mol Immunol 46:2892-2901
3. Betteridge DJ (2000) What is oxidative stress? Metabolism 49(2 Suppl 1):3-8
4. Chadwick M, Trewin H, Gawthrop F, Wagstaff C (2013) Sesquiterpenoids lactones: benefits to plants and people. Int J Mol Sci 14:12780-12805
5. Chaiswing L, Oberley TD (2010) Extracellular/microenvironmental redox state. Antioxid Redox Signal 13:449-465
6. Choi JH, Lee KT (2009) Costunolide-induced apoptosis in human leukemia cells: involvement of c-jun N-terminal kinase activation. Biol Pharm Bull 32:1803-1808
7. Circu ML, Aw TY (2008) Glutathione and apoptosis. Free Radic Res 42:689-706
8. Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749-762
9. D'Anneo A, Carlisi D, Lauricella M, Puleio R, Martinez R, Di Bella S, Di Marco P, Emanuele S, Di Fiore R, Guercio A, Vento R, Tesoriere G (2013) Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer. Cell Death Dis 4:e891
10. Diamanti P, Cox CV, Moppett JP, Blair A (2013) Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia. Blood 121:1384-1393
11. Fang J, Seki T, Maeda H (2009) Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 61:290-302
12. Fonrose X, Ausseil F, Soleilhac E, Masson V, David B, Pouny I, Cintrat JC, Rousseau B, Barette C, Massiot G, Lafanechère L (2007) Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res 67:3371-3378
13. Friesen C, Kiess Y, Debatin KM (2004) A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ 11(Suppl 1):S73-S85
14. Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ (2003) Function of nuclear factor kappaB in pancreatic cancer metastasis. Clin Cancer Res 9:346-354
15. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, Holmdahl R (2006) T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci U S A 103:12831-12836
16. Gopal YN, Arora TS, Van Dyke MW (2007) Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated. Chem Biol 14:813-823
17. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Jordan CT (2001) Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98:2301-2307
18. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105:4163-4169
19. Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT (2007) An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110:4427-4435
20. Halliwell B, Cross CE (1994) Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102(Suppl 10):5-12
21. Hayashi S, Koshiba K, Hatashita M, Sato T, JujoY SR, Tanaka Y, Shioura H (2011) Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines. Int J Mol Med 28:1033-1042
22. Heilmann J, Wasescha MR, Schmidt TJ (2001) The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells. Bioorg Med Chem 9:2189-2194
23. Irshad M, Chaudhuri PS (2002) Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol 40:1233-1239
24. Itoh T, Ito Y, Ohguchi K, Ohyama M, Iinuma M, Otsuki M, Nozawa Y, Akao Y (2008) Eupalinin A isolated from Eupatorium chinense L. induces autophagocytosis in human leukemia HL60 cells. Bioorg Med Chem 16:721-731
25. Itoh T, Ohguchi K, Nozawa Y, Akao Y (2009) Intracellular glutathione regulates sesquiterpene lactone-induced conversion of autophagy to apoptosis in human leukemia HL60 cells. Anticancer Res 29:1449-1457
26. Janecka A, Wyrębska A, Gach K, Fichna J, Janecki T (2012) Natural and synthetic α-methylenelactones and α-methylenelactams with anticancer potential. Drug Discov Today 17:561-572
27. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227
28. Kevin P (2010) New agents for the treatment of leukemia: discovery of DMAPT (LC-1). Drug Discov Today 15:322
29. Khan M, Yi F, Rasul A, Li T, Wang N, Gao H, Gao R, Ma T (2012) Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life 64:783-794
30. Khan M, Li T, Ahmad Khan MK, Rasul A, Nawaz F, Sun M, Zheng Y, Ma T (2013) Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. Biomed Res Int 2013:719858
31. Knight DW (1995) Feverfew: chemistry and biological activity. Nat Prod Rep 12:271-276
32. Koprowska K, Czyz M (2010) Molecular mechanisms of parthenolide's action: old drug with a new face. Postepy Hig Med Dosw (Online) 64:100-114
33. Kreuger MR, Grootjans S, Biavatti MW, Vandenabeele P, D'Herde K (2012) Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Drugs 23:883-896
34. Lee KH, Furukawa H (1972) Antitumor agents. 3. Synthesis and cytotoxic activity of helenalin amine adducts and related derivatives. J Med Chem 15:609-611
35. Lee KH, Hall IH, Mar EC, Starnes CO, ElGebaly SA, Waddell TG, Hadgraft RI, Ruffner CG, Weidner I (1977) Sesquiterpene antitumor agents: inhibitors of cellular metabolism. Science 196:533-536
36. Lee MG, Lee KT, Chi SG, Park JH (2001) Costunolide induces apoptosis by ROS-mediated mitochondrial permeability transition and cytochrome C release. Biol Pharm Bull 24:303-306
37. Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, Chen P, Aimiuwu J, Pang J, Bhasin D, Neviani P, Fuchs JR, Plass C, Li PK, Li C, Huang TH, Wu LC, Rush L, Wang H, Perrotti D, Marcucci G, Chan KK (2009) Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J Pharmacol Exp Ther 329:505-514
38. Liu JW, Cai MX, Xin Y, Wu QS, Ma J, Yang P, Xie HY, Huang DS (2010) Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro. J Exp Clin Cancer Res 29:108
39. Mathema VB, Koh YS, Thakuri BC, Sillanpää M (2012) Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities. Inflammation 35:560-565
40. Mazor RL, Menendez IY, Ryan MA, Fiedler MA, Wong HR (2000) Sesquiterpene lactones are potent inhibitors of interleukin 8 gene expression in cultured human respiratory epithelium. Cytokine 12:239-245
41. Merfort I (2011) Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets 12:1560-1573
42. Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, Campas C, Suarez M, Fabregat X, Campo E, Gascon P, Serrano S, Fernandez L, Rovira A, Albanell J (2006) Activation of nuclear factor-κB is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer 13:607-616
43. Nakshatri H, Rice SE, Bhat-Nakshatri P (2004) Antitumor agent parthenolide reverses resistance of breast cancer cells to tumour necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase. Oncogene 23:7330-7344
44. Nasim S, Crooks PA (2008) Antileukemic activity of aminoparthenolide analogs. Bioorg Med Chem Lett 18:3870-3873
45. Neelakantan S, Nasim S, Guzman ML, Jordan CT, Crooks PA (2009) Aminoparthenolides as novel anti-leukemic agents: discovery of the NF-kappaB inhibitor, DMAPT (LC-1). Bioorg Med Chem Lett 19:4346-4349
46. Nogueira V, Hay N (2013) Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res 19:4309-4314
47. Pati HN, Das U, Sharma RK, Dimmock JR (2007) Cytotoxic thiol alkylators. Mini Rev Med Chem 7:131-139
48. Rasul A, Bao R, Malhi M, Zhao B, Tsuji I, Li J, Li X (2013) Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction. Molecules 18:1418-1433
49. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603-1616
50. Rüngeler P, Castro V, Mora G, Gören N, Vichnewski W, Pahl HL, Merfort I, Schmidt TJ (1999) Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg Med Chem 7:2343-2352
51. Salla M, Fakhoury I, Saliba N, Darwiche N, Gali-Muhtasib H (2013) Synergistic anticancer activities of the plant-derived sesquiterpene lactones salograviolide A and iso-seco-tanapartholide. J Nat Med 67:468-479
52. Schomburg C, Schuehly W, da Costa FB, Klempnauer K-H, Schmidt TJ (2013) Natural sesquiterpene Lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships. Eur J Med Chem 63:313-320
53. Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10:175-176
54. Scotti MT, Fernandes MB, Ferreira MJ, Emerenciano VP (2007) Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity. Bioorg Med Chem 15:2927-2934
55. Shanmugam R, Kusumanchi P, Cheng L, Crooks P, Neelakantan S, Matthews W, Nakshatri H, Sweeney CJ (2010) A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species. Prostate 70:1074-1086
56. Shanmugam R, Kusumanchi P, Appaiah H, Cheng L, Crooks P, Neelakantan S, Peat T, Klaunig J, Matthews W, Nakshatri H, Sweeney CJ (2011) A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species. Int J Cancer 128:2481-2494
57. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E (2007) Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 6:2544-2553
58. Skalska J, Brookes PS, Nadtochiy SM, Hilchey SP, Jordan CT, Guzman ML, Maggirwar SB, Brieh MM, Bernstein SH (2009) Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide. PLoS One 4:e8115
59. Song JM, Qian X, Upadhyayya P, Hong KH, Kassie F (2014) Dimethylaminoparthenolide, a water soluble parthenolide, suppresses lung tumorigenesis through down-regulating the STAT3 signaling pathway. Curr Cancer Drug Targets 14:59-69
60. Steele AJ, Jones DT, Ganeshaguru K, Duke VM, Yogashangary BC, North JM, Lowdell MW, Kottaridis PD, Mehta AB, Prentice AG, Hoffbrand AV, Wickremasinghe RG (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia 20:1073-1079
61. Suvannasankha A, Crean CD, Shanmugam R, Farag SS, Abonour R, Boswell HS, Nakshatri H (2008) Antimyeloma effects of a sesquiterpene lactone parthenolide. Clin Cancer Res 14:1814-1822
62. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794-798
63. Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995) Persistent oxidative stress in cancer. FEBS Lett 358:1-3
64. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84
65. Visconti R, Grieco D (2009) New insights on oxidative stress in cancer. Curr Opin Drug Discov Dev 12:240-245
66. Wang W, Adachi M, Kawamura R, Sakamoto H, Hayashi T, Ishida T, Imai K, Shinomura Y (2006) Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity. Apoptosis 11:2225-2235
67. Wen J, You KR, Lee SY, Song CH, Kim DG (2002) Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 277:38954-38964
68. Woerdenbag HJ, Lemstra W, Malingre TM, Konings AW (1989) Enhanced cytostatic activity of the sesquiterpene lactone eupatoriopicrin by glutathione depletion. Br J Cancer 59:68-75
69. Wong HR, Menendez IY (1999) Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 262:375-380
70. Wyrebska A, Gach K, Janecka A (2014) Mini Rev combined effect of parthenolide and various anti-cancer drugs or anticancer candidate substances on malignant cells in vitro and in vivo. Med Chem 14:222-228
71. Zhang S, Ong CN, Shen HM (2004) Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells. Cancer Lett 208:143-153
72. Zhang S, Won YK, Ong CN, Shen HM (2005) Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anticancer Agents 5:239-249
73. Zhang Q, LuY DY, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J, Tong Z, Shi Y, Jia Y, Han B, Zhang W, Qiu C, Ma X, Li Q, Shi Q, Zhang H, Li D, Zhang J, Lin J, Li LY, Gao Y, Chen Y (2012) Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem 55:8757-8769
74. Zhang Y, Bao YL, Wu Y, Yu CL, Huang YX, Sun Y, Zheng LH, Li YX (2013) Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway. Mol Med Rep 8:967-972
75. Zhangabylov NS, Yu Dederer L, Gorbacheva LB, Vasil'eva SV, Terekhov AS (2004) Adekenov SM Sesquiterpene lactone arglabin influences DNA synthesis in P388 leukemia cells in vivo. Pharm Chem J 38:651-653
76. Zheng B, Wu L, Ma L, Liu S, Li L, Xie W, Li X (2013) Telekin induces apoptosis associated with the mitochondria-mediated pathway in human hepatocellular carcinoma cells. Biol Pharm Bull 36:1118-1125
77. Zunino SJ, Ducore JM, Storms DH (2007) Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells. Cancer Lett 254:119-127